TGA Initiates Court Proceedings Against Medtronic Australasia

The Therapeutic Goods Administration (TGA) has announced they are initiating court proceedings against Medtronic Australasia Pty Ltd for the alleged unlawful supply of the Infuse Bone Graft Kit.

The Infuse Bone Graft Kit contained a medicine, and other components, used to stimulate bone growth in patients.

The RACS has notified all specialties as there can be multidisciplinary care e.g. sarcoma involving more than orthopaedic surgeons and neurosurgeons. It is important to note that there is no suggestion surgeons or hospitals are at fault or at risk of legal proceedings.

For more information, please access the Notice of Filing from the TGA.